Form 4 for PLX Protalix BioTherapeutics, Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-18 · accession 0001385113-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 2025-11-18 | PLX | Bar-Shalev Amos | Dir | S - Sale | $1.87 | -168 | 0 | -100% | -$314.16 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-18 | S | D | 168 | $1.87 | 0 | D | — | — |